(Q33572336)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10160478%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

review article

1 reference

title

Statistical analysis in pharmacoeconomic studies. A review of current issues and standards (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10160478%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10160478%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

Coyle D

series ordinal

1

1 reference

28 July 2017

1 June 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10160478%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10160478%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10160478%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10160478%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

506-516

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10160478%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-199609060-00005

2 December 2019

exact match

0 references

cites work

Health care CBA/CEA: an update on the growth and composition of the literature.

1 reference

12 December 2020

A comparative trial of home and hospital psychiatric treatment: financial costs

1 reference

12 December 2020

Statistical versus quantitative significance in the socioeconomic evaluation of medicines

1 reference

12 December 2020

Guidelines for pharmacoeconomic studies

1 reference

12 December 2020

Economic analysis of an immunosuppressive strategy in renal transplantation

1 reference

12 December 2020

Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands

1 reference

12 December 2020

In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care

1 reference

12 December 2020

The cost:benefit ratio of acute intervention for myocardial infarction: results of a prospective, matched pair analysis

1 reference

12 December 2020

Methodological issues in economic assessments of new therapies. The case of colony-stimulating factors

1 reference

12 December 2020

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

1 reference

12 December 2020

Economic analysis in randomized control trials

1 reference

12 December 2020

Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer

1 reference

12 December 2020

Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada

1 reference

12 December 2020

A cost-utility analysis of misoprostol prophylaxis for rheumatoid arthritis patients receiving nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Statistical analysis of cost outcomes in a randomized controlled clinical trial

1 reference

12 December 2020

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

12 December 2020

The cost effectiveness of auranofin: results of a randomized clinical trial

1 reference

12 December 2020

Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

1 reference

12 December 2020

The impact of age on the cost-effectiveness of hypertension treatment: an analysis of randomized drug trials.

1 reference

12 December 2020

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

1 reference

12 December 2020

Effects of the use of AZT on the medical care costs of persons with AIDS in the first 12 months.

1 reference

12 December 2020

Does expenditure on pharmaceuticals give good value for money?: current evidence and policy implications

1 reference

12 December 2020

Guidelines for pharmacoeconomic studies. The ways forward

1 reference

12 December 2020

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

1 reference

12 December 2020

Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia

1 reference

12 December 2020

Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer

1 reference

12 December 2020

Cost of surfactant replacement treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial

1 reference

12 December 2020

Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints

1 reference

12 December 2020

Cost and procedure implications of thrombolytic therapy for acute myocardial infarction

1 reference

12 December 2020

Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients

1 reference

12 December 2020